A novel near-infrared trifluoromethyl heptamethine cyanine dye with mitochondria-targeting for integration of collaborative treatment of photothermal and sonodynamic therapy
Source abstract
Abstract
Both photothermal therapy (PTT) and sonodynamic therapy (SDT) are neoteric therapeutic method for tumor control and ablation without invasive. Herein, we report the synthesis of a newly designed near-infrared (NIR) trifluoromethyl-heptamethine cyanine (TFHC) dye, which could synergistically work as a mitochondrial-targeting sonosensitizer for SDT and also a photothermal therapy agent (PTA) for PTT. The structure and chemical components of TFHC were determined by 1H NMR and mass spectrum (MS). Furthermore, the introduce of trifluoromethyl was proved drastically improving the biocompatibility of TFHC. Moreover, TFHC was capable to kill cancer cells with a high efficiency (80%) under NIR and ultrasound (US) without causing any significant side effects. In general, the prepared mitochondria-targeting TFHC obtains the synergy effect for the PTT and SDT with excellent therapeutic effects and low side effects, which can be harnessed for the combinational cancer non-invasive therapy in the near future.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. Near Infrared (NIR) absorbing dyes as promising photosensitizer for photo dynamic therapy10.1016/j.ccr.2020.213233 ↗
2. Recent advances in nanomaterial-assisted combinational sonodynamic cancer therapy10.1002/adma.202003214 ↗
3. Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery10.1039/C8BM00226F ↗
4. Cancer statistics, 2021
5. Cell death in photodynamic therapy: from oxidative stress to anti-tumor immunity10.1016/j.bbcan.2019.07.003 ↗
6. Aptamer-targeted photodynamic platforms for tumor therapy10.1021/acsami.1c06818 ↗
7. Mitochondrion-targeted platinum complexes suppressing lung cancer through multiple pathways involving energy metabolism10.1039/C8SC04871A ↗
8. New designs for phototherapeutic transition metal complexes10.1002/anie.201905171 ↗
9. Targeting the thioredoxin system as a strategy for cancer therapy10.1021/acs.jmedchem.8b01595 ↗
10. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
11. Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy10.1016/j.biomaterials.2020.120636 ↗
12. Sonodynamic therapy10.1016/j.ultras.2008.02.003 ↗
13. Ultrafine titanium monoxide (TiO(1+x)) nanorods for enhanced sonodynamic therapy10.1021/jacs.9b10228 ↗
14. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke
15. Multifunctional sonosensitizers in sonodynamic cancer therapy10.1039/C9CS00648F ↗
16. Sonodynamic therapy: a potential treatment for atherosclerosis10.1016/j.lfs.2018.06.018 ↗
17. Advanced biotechnology-assisted precise sonodynamic therapy10.1039/D1CS00403D ↗
18. Sonodynamic therapy-derived multimodal synergistic cancer therapy10.1016/j.canlet.2020.10.037 ↗
19. Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancer10.1016/j.canlet.2021.06.003 ↗
20. Organic sonosensitizers for sonodynamic therapy: from small molecules and nanoparticles toward clinical development10.1002/smll.202101976 ↗
21. Design and application of inorganic nanoparticles for sonodynamic cancer therapy10.1039/D0BM01875A ↗
22. Mechanically controlled radical polymerization initiated by ultrasound10.1038/nchem.2633 ↗
23. Curcumin-gold-polyethylene glycol nanoparticles as a nanosensitizer for photothermal and sonodynamic therapies: in vitro and animal model studies10.1016/j.pdpdt.2020.102139 ↗
24. A honeycomb-like bismuth/manganese oxide nanoparticle with mutual reinforcement of internal and external response for triple-negative breast cancer targeted therapy10.1002/adhm.202100518 ↗
25. Titania-coated 2D gold nanoplates as nanoagents for synergistic photothermal/sonodynamic therapy in the second near-infrared window10.1039/C8NR07188H ↗
26. Wu · 2022
27. Prototypic heptamethine cyanine incorporating nanomaterials for cancer phototheragnostic10.1002/adhm.201901665 ↗
28. Near-infrared light-triggered nitric-oxide-enhanced photodynamic therapy and low-temperature photothermal therapy for biofilm elimination10.1021/acsnano.9b09871 ↗
29. Nanosonosensitizer-Augmented sonodynamic therapy combined with checkpoint blockade for cancer immunotherapy10.2147/IJN.S290796 ↗
30. Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death10.1038/s41467-019-11269-8 ↗
31. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
32. Role of trifluoromethyl substitution in design of antimalarial quinolones: a comprehensive review10.1007/s41061-019-0234-7 ↗
33. The importance of trifluoromethyl pyridines in crop protection10.1002/ps.4806 ↗
34. Sonodynamic therapy: ultrasound parameters and in vitro experimental configurations10.1016/j.ijpharm.2021.121243 ↗
35. Sonodynamic therapy for the treatment of intracranial gliomas
36. Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice10.1038/s41467-019-09760-3 ↗
37. Current landscape of sonodynamic therapy for treating cancer10.3390/cancers13246184 ↗
38. Current status and future perspectives of sonodynamic therapy in glioma treatment10.1016/j.ultsonch.2017.02.020 ↗
39. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors10.7150/thno.45511 ↗
40. Sonosensitizer-functionalized graphene nanoribbons for adhesion blocking and sonodynamic ablation of ovarian cancer spheroids10.1002/adhm.202001368 ↗
41. A highly potent ruthenium(II)-sonosensitizer and sonocatalyst for in vivo sonotherapy10.1038/s41467-021-25303-1 ↗
42. A robust oxygen-carrying hemoglobin-based natural sonosensitizer for sonodynamic cancer therapy10.1021/acs.nanolett.1c01220 ↗
43. A high-performance nanobio photocatalyst for targeted brain cancer therapy10.1021/nl901610f ↗
44. Reactive oxygen species, cellular redox systems, and apoptosis10.1016/j.freeradbiomed.2009.12.022 ↗
45. Targeting mitochondrial ion channels for cancer therapy10.1016/j.redox.2020.101846 ↗
46. Targeting the mitochondrial chaperone TRAP1: strategies and therapeutic perspectives10.1016/j.tips.2021.04.003 ↗
47. Mitochondrial metabolism and cancer10.1038/cr.2017.155 ↗
48. The cellular and molecular basis of hyperthermia10.1016/S1040-8428(01)00179-2 ↗